AAAAAA
Results: 1-25/33
Authors:
Weigmann, H
Hartter, S
Maehrlein, S
Kiefer, W
Kramer, G
Dannhardt, G
Hiemke, C
Citation: H. Weigmann et al., Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography, J CHROMAT B, 759(1), 2001, pp. 63-71
Authors:
Dahmen, N
Muller, MJ
Germeyer, S
Rujescu, D
Anghelescu, I
Hiemke, C
Wetzel, H
Citation: N. Dahmen et al., Genetic polymorphisms of the dopamine D-2 and D-3 receptor and neurolepticdrug effects in schizophrenic patients, SCHIZOPHR R, 49(1-2), 2001, pp. 223-225
Authors:
Rao, ML
Hiemke, C
Grasmader, K
Baumann, P
Citation: Ml. Rao et al., Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring, F NEUR PSYC, 69(11), 2001, pp. 510-517
Authors:
Schirrmacher, R
Hamkens, W
Piel, M
Schmitt, U
Luddens, H
Hiemke, C
Rosch, F
Citation: R. Schirrmacher et al., Radiosynthesis of (+/-)-(2-((4-(2-[F-18]fluoroethoxy)phenyl)bis(4-methoxy-phenyl) methoxy)ethylpiperidine-3-carboxylic acid: a potential GAT-3 PET ligand to study GABAergic neuro-transmission in vivo, J LABEL C R, 44(9), 2001, pp. 627-642
Authors:
Fehr, C
Schleicher, A
Szegedi, A
Anghelescu, I
Klawe, C
Hiemke, C
Dahmen, N
Citation: C. Fehr et al., Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy, PROG NEUR-P, 25(5), 2001, pp. 965-982
Authors:
Schmitt, U
Luddens, H
Hiemke, C
Citation: U. Schmitt et al., Behavioral analysis indicates benzodiazepine-tolerance mediated by the benzodiazepine binding-site at the GABA(A)-receptor, PROG NEUR-P, 25(5), 2001, pp. 1145-1160
Authors:
Hartter, S
Wang, XM
Weigmann, H
Friedberg, T
Arand, M
Oesch, F
Hiemke, C
Citation: S. Hartter et al., Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin, J CL PSYCH, 21(2), 2001, pp. 167-174
Authors:
Muller, MJ
Hartter, S
Kohler, D
Hiemke, C
Citation: Mj. Muller et al., Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: A pilot study, PHARMACOPS, 34(1), 2001, pp. 27-32
Authors:
Weigmann, H
Gerek, S
Zeisig, A
Muller, M
Hartter, S
Hiemke, C
Citation: H. Weigmann et al., Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service, THER DRUG M, 23(4), 2001, pp. 410-413
Authors:
Hartter, S
Weigmann, H
Hiemke, C
Citation: S. Hartter et al., Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection, J CHROMAT B, 740(1), 2000, pp. 135-140
Authors:
Weigmann, H
Hartter, S
Bagli, M
Hiemke, C
Citation: H. Weigmann et al., Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine, EUR NEUROPS, 10(5), 2000, pp. 401-405
Authors:
Dahmen, N
Pauly, T
Szegedi, A
Wetzel, H
Anghelescu, I
Ferdinand, K
Hiemke, C
Citation: N. Dahmen et al., Adenylyl cyclase activity is increased in younger, but decreased in older,alcoholic patients after detoxification, ALC ALCOHOL, 35(3), 2000, pp. 249-254
Authors:
Schlosser, R
Wetzel, H
Dorr, H
Rossbach, W
Hiemke, C
Benkert, O
Citation: R. Schlosser et al., Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers, PSYCHONEURO, 25(4), 2000, pp. 377-388
Authors:
Fehr, C
Grunder, G
Hiemke, C
Dahmen, N
Citation: C. Fehr et al., Increase in serum clomipramine concentrations caused by valproate, J CL PSYCH, 20(4), 2000, pp. 493-494
Authors:
Fehr, C
Grintschuk, N
Szegedi, A
Anghelescu, I
Klawe, C
Singer, P
Hiemke, C
Dahmen, N
Citation: C. Fehr et al., The HTR1B 861G > C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy, PSYCHIAT R, 97(1), 2000, pp. 1-10
Authors:
Hiemke, C
Hartter, S
Citation: C. Hiemke et S. Hartter, Pharmacokinetics of selective serotonin reuptake inhibitors, PHARM THERA, 85(1), 2000, pp. 11-28
Authors:
Van Kampen, M
Schmitt, U
Hiemke, C
Fuchs, E
Citation: M. Van Kampen et al., Diazepam has no beneficial effects on stress-induced behavioural and endocrine changes in male tree shrews, PHARM BIO B, 65(3), 2000, pp. 539-546
Authors:
Schmitt, U
Luddens, H
Hiemke, C
Citation: U. Schmitt et al., Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition, PHARM BIO B, 65(2), 2000, pp. 351-356
Authors:
Hartter, S
Grozinger, M
Weigmann, H
Roschke, J
Hiemke, C
Citation: S. Hartter et al., Increased bioavailability of oral melatonin after fluvoxamine coadministration, CLIN PHARM, 67(1), 2000, pp. 1-6
Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile
Authors:
Grozinger, M
Hartter, S
Wang, XM
Roschke, J
Hiemke, C
Citation: M. Grozinger et al., Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile, ARCH G PSYC, 57(8), 2000, pp. 812-813
Authors:
Ulrich, S
Kruggel, S
Weigmann, H
Hiemke, C
Citation: S. Ulrich et al., Fishing for a drug: solid-phase microextraction for the assay of clozapinein human plasma, J CHROMAT B, 731(2), 1999, pp. 231-240
Authors:
Schmitt, U
Hiemke, C
Citation: U. Schmitt et C. Hiemke, Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze, BEHAV PHARM, 10(2), 1999, pp. 131-137
Authors:
Weigmann, H
Hartter, S
Fischer, V
Dahmen, N
Hiemke, C
Citation: H. Weigmann et al., Distribution of clozapine and desmethylclozapine between blood and brain in rats, EUR NEUROPS, 9(3), 1999, pp. 253-256
Authors:
Reuss, S
Hermes, B
Fuchs, E
Hiemke, C
Citation: S. Reuss et al., Day- and night-time contents of monoamines and their metabolites in the medial preoptic area of the rat hypothalamus, NEUROSCI L, 266(1), 1999, pp. 29-32
Authors:
Schmitt, U
Dahmen, N
Fischer, V
Weigmann, H
Rao, ML
Reuss, S
Hiemke, C
Citation: U. Schmitt et al., Chronic oral haloperidol and clozapine in rats: A behavioral evaluation, NEUROPSYCHB, 39(2), 1999, pp. 86-91